| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.26B | 1.58B | 1.63B | 1.38B | 1.10B |
| Gross Profit | 29.90M | 583.90M | 639.20M | 450.70M | 343.70M |
| EBITDA | 120.50M | 237.80M | 309.60M | -5.40M | 150.70M |
| Net Income | -493.20M | -323.50M | -228.10M | -527.70M | -189.30M |
Balance Sheet | |||||
| Total Assets | 2.81B | 3.16B | 3.17B | 3.10B | 2.84B |
| Cash, Cash Equivalents and Short-Term Investments | 252.90M | 359.60M | 392.40M | 592.10M | 426.20M |
| Total Debt | 1.67B | 1.48B | 1.17B | 1.31B | 1.29B |
| Total Liabilities | 2.48B | 2.41B | 2.25B | 2.33B | 2.18B |
| Stockholders Equity | 316.30M | 740.20M | 902.30M | 753.00M | 641.80M |
Cash Flow | |||||
| Free Cash Flow | -137.10M | -276.70M | -251.50M | -159.80M | -5.80M |
| Operating Cash Flow | -67.50M | 123.90M | 145.90M | 127.10M | 178.90M |
| Investing Cash Flow | -232.50M | -374.80M | -383.40M | -284.70M | -184.10M |
| Financing Cash Flow | 196.60M | 215.80M | 59.70M | 315.00M | -66.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £238.73M | 27.31 | 8.70% | 0.63% | 3.10% | 23.59% | |
71 Outperform | £182.61M | 3.31 | 4.55% | 3.22% | -0.17% | -10.96% | |
70 Outperform | £2.87B | 10.60 | 23.83% | 3.44% | -15.99% | 69.97% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | £92.82M | 12.59 | 16.70% | 1.48% | 20.64% | ― | |
44 Neutral | £381.70M | -1.27 | -96.24% | ― | -7.90% | 18.13% |